The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health ...

Drugmakers are likewise reaching out to other employers with the message that treating obesity will ultimately save them money.

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

On a spring day this year, the New Jersey State Policemen’s Benevolent Association received three unusual visitors: ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

If you’ve noticed ads for weight loss injections flood your social media feeds, you’re not alone. The soaring popularity of ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

Government health plans in the U.S. provide significant coverage for new weight-loss drugs, overshadowing private insurers.